Acute Myelogenous Leukemia: Clinical Trials

1 trial for Acute Myelogenous Leukemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 11Completed 1

Follow Acute Myelogenous Leukemia: new trials by email Literature Review of Acute Myelogenous Leukemia trials Research Report on Acute Myelogenous Leukemia

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intra-Osseous Co-Transplant of UCB and hMSC
cyclophosphamide, fludarabine phosphate, total-body irradiation - Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia
Early Phase 1CompletedCase Comprehensive Cancer Center62015-07-222020-12-04

Narrower conditions

Hodgkin Disease (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Myelodysplastic Syndromes (1)  ·  Neoplasms (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)  ·  Primary Myelofibrosis (1)

Broader conditions

Bone Marrow Diseases (1)  ·  Chronic Disease (1)  ·  Disease Attributes (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Leukemia (1)  ·  Leukemia, B-Cell (1)  ·  Leukemia, Lymphoid (1)  ·  Leukemia, Myeloid (1)  ·  Lymphatic Diseases (1)  ·  Lymphoma (1)  ·  Lymphoproliferative Disorders (1)  ·  Myeloproliferative Disorders (1)

Interventions

Cord Blood Stem Cell Transplantation (1)  ·  Cyclophosphamide (1)  ·  Cyclosporine (1)  ·  Mesenchymal Stem Cell Transplantation (1)  ·  Mycophenolic Acid (1)  ·  Transplantation (1)  ·  Whole-Body Irradiation (1)  ·  fludarabine phosphate (1)

Sponsors

Case Comprehensive Cancer Center (1)

Countries

United States (1)

Top investigators

Leland Metheny, MD (1)

NIH funding

P30CA043703 (1)